Evaluation of the Six Minute Walk Test and Other Instruments in Heart Failure

NCT ID: NCT01736137

Last Updated: 2014-08-07

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

17 participants

Study Classification

OBSERVATIONAL

Study Start Date

2011-11-30

Study Completion Date

2014-02-28

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The purpose of this study is to assess functional capacity, quality of life and functioning of the autonomic nervous system in heart failure patients on beta-blocker treatment. The study hypothesis is that subjects who walk less distance, have lower quality of life and reduced heart rate variability during the six minute walk test.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Heart failure and its treatment result in symptoms such as pulmonary or systemic congestion causing impairment to the effort, psychological and social commitment, and impact on quality of life.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Heart Failure Autonomic Nervous System Imbalance Heart Rate and Rhythm Disorders Quality of Life

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

CASE_CONTROL

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Chronic Heart failure group

All chronic heart failure group participants will perform two walk tests at the same day, with a heart rate monitor, and answer questionnaires about their perception of quality of life. Tests will be conducted on a single day, without follow up of patients. The six minute walk test will be performed according the American Thoracic Society Statement (2002).

Six minute walk test

Intervention Type OTHER

If patients meet the criteria of the study, their data will be collected and will be interviewed to fill the Minnesota Living with Heart Failure Questionnaire (MLHFQ). They then will be taken to the hallway to perform the six minute walk test monitored with a heart rate monitor (Polar RS800 CX). After the test there will be a break of 20 to 30 minutes before repeating the walk test. During rest time, the patient will answer the general health survey questionnaire: Medical Outcome Study 36-item Short-Form Health Survey (SF-36).

Control Group

All control group participants will perform two walk tests at the same day, with a heart rate monitor, and answer questionnaires about their perception of quality of life. Tests will be conducted on a single day, without follow up of patients. The six minute walk test will be performed according the American Thoracic Society Statement (2002).

Six minute walk test

Intervention Type OTHER

If patients meet the criteria of the study, their data will be collected and will be interviewed to fill the Minnesota Living with Heart Failure Questionnaire (MLHFQ). They then will be taken to the hallway to perform the six minute walk test monitored with a heart rate monitor (Polar RS800 CX). After the test there will be a break of 20 to 30 minutes before repeating the walk test. During rest time, the patient will answer the general health survey questionnaire: Medical Outcome Study 36-item Short-Form Health Survey (SF-36).

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Six minute walk test

If patients meet the criteria of the study, their data will be collected and will be interviewed to fill the Minnesota Living with Heart Failure Questionnaire (MLHFQ). They then will be taken to the hallway to perform the six minute walk test monitored with a heart rate monitor (Polar RS800 CX). After the test there will be a break of 20 to 30 minutes before repeating the walk test. During rest time, the patient will answer the general health survey questionnaire: Medical Outcome Study 36-item Short-Form Health Survey (SF-36).

Intervention Type OTHER

Other Intervention Names

Discover alternative or legacy names that may be used to describe the listed interventions across different sources.

MLHFQ SF-36 Heart rate variability (Polar RS800 CX)

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Both sexes
* Different etiologies of Heart Failure
* Functional class I - III (NYHA)
* Left ventricular ejection fraction (LVEF) ≤ 50%
* No history of previous cardiac surgery
* In return for medical evaluation at the Amelio Marques Clinic, Hospital de Clinicas, Federal University of Uberlândia scheduled for the period from October 2012 to January 2013
* Clinical stability observed by: heart rate, respiratory rate, blood pressure and arterial oxygen saturation

Exclusion Criteria

* Bad cognition compromising the understanding of tests
* Physical disability that compromise the performance in walk test
* Aortic aneurysm or any aortic deformity
* Patients with signs or symptoms of transient myocardial ischemia with angina pectoris and/or class IV by the Canadian Cardiovascular Society Classification
* Anomalous pressure behavior with hypertension \> 180/100 mmHg
* Orthostatic hypotension (decrease \> 15 mmHg ) with symptoms
* Arrhythmia with presence of complex ventricular extra systoles
* Tachycardia sinus at rest (HR \> 120 beats/min)
* Atrioventricular block of 2nd or 3rd degree
* Subjects with pacemakers or implantable cardioverter-defibrillator (ICD)
* Functional class IV by the New York Heart Association
* Chronic organ dysfunction such as renal failure, respiratory or liver disease
* Active neoplasia over the past five years
* Commitment as general weakness, fever, other limiting factors (psychological, musculoskeletal)
* Feeling sick before the beginning of the Six minute walk test: intolerable angina or dyspnea, cramps in legs, staggering gait, excessive sweating (diaphoresis), pallor or ashen skin or SpO2 below 85%
* Voluntary desire of the patient to withdraw from research
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Federal University of Uberlandia

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Débora Lara Zuza Scheucher

Physiotherapist

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Celia R Lopes, PhD

Role: STUDY_CHAIR

Federal University of Uberlandia

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Amelio Marques Clinic

Uberlândia, Minas Gerais, Brazil

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Brazil

References

Explore related publications, articles, or registry entries linked to this study.

ATS Committee on Proficiency Standards for Clinical Pulmonary Function Laboratories. ATS statement: guidelines for the six-minute walk test. Am J Respir Crit Care Med. 2002 Jul 1;166(1):111-7. doi: 10.1164/ajrccm.166.1.at1102. No abstract available.

Reference Type BACKGROUND
PMID: 12091180 (View on PubMed)

Bocchi EA, Braga FG, Ferreira SM, Rohde LE, Oliveira WA, Almeida DR, Moreira Mda C, Bestetti RB, Bordignon S, Azevedo C, Tinoco EM, Rocha RM, Issa VS, Ferraz A, Cruz Fd, Guimaraes GV, Montera Vdos S, Albuquerque DC, Bacal F, Souza GE, Rossi Neto JM, Clausell NO, Martins SM, Siciliano A, Souza Neto JD, Moreira LF, Teixeira RA, Moura LZ, Beck-da-Silva L, Rassi S, Azeka E, Horowitz E, Ramires F, Simoes MV, Castro RB, Salemi VM, Villacorta Junior H, Vila JH, Simoes R, Albanesi F, Montera MW; Sociedasde Brasileira de Cardiologia. [III Brazilian Guidelines on Chronic Heart Failure]. Arq Bras Cardiol. 2009;93(1 Suppl 1):3-70. No abstract available. Portuguese.

Reference Type BACKGROUND
PMID: 20963312 (View on PubMed)

Bocchi EA, Marcondes-Braga FG, Bacal F, Ferraz AS, Albuquerque D, Rodrigues Dde A, Mesquita ET, Vilas-Boas F, Cruz F, Ramires F, Villacorta H Jr, Souza Neto JD, Rossi Neto JM, Moura LZ, Beck-da-Silva L, Moreira LF, Rohde LE, Montera MW, Simoes MV, Moreira Mda C, Clausell N, Bestetti R, Mourilhe-Rocha R, Mangini S, Rassi S, Ayub-Ferreira SM, Martins SM, Bordignon S, Issa VS. [Updating of the Brazilian guideline for chronic heart failure - 2012]. Arq Bras Cardiol. 2012 Jan;98(1 Suppl 1):1-33. doi: 10.1590/s0066-782x2012001000001. No abstract available. Portuguese.

Reference Type BACKGROUND
PMID: 22392082 (View on PubMed)

Borg GA. Psychophysical bases of perceived exertion. Med Sci Sports Exerc. 1982;14(5):377-81.

Reference Type BACKGROUND
PMID: 7154893 (View on PubMed)

Reis MS, Deus AP, Simoes RP, Aniceto IA, Catai AM, Borghi-Silva A. Autonomic control of heart rate in patients with chronic cardiorespiratory disease and in healthy participants at rest and during a respiratory sinus arrhythmia maneuver. Rev Bras Fisioter. 2010 Mar-Apr;14(2):106-13. Epub 2010 May 7. English, Portuguese.

Reference Type BACKGROUND
PMID: 20464168 (View on PubMed)

Carvalho VO, Guimaraes GV, Carrara D, Bacal F, Bocchi EA. Validation of the Portuguese version of the Minnesota Living with Heart Failure Questionnaire. Arq Bras Cardiol. 2009 Jul;93(1):39-44. doi: 10.1590/s0066-782x2009000700008. English, Portuguese, Spanish.

Reference Type BACKGROUND
PMID: 19838469 (View on PubMed)

Dantas RA, Sawada NO, Malerbo MB. [Research on quality of life: review of the scientific production of public universities from the state of Sao Paulo]. Rev Lat Am Enfermagem. 2003 Jul-Aug;11(4):532-8. doi: 10.1590/s0104-11692003000400017. Portuguese.

Reference Type BACKGROUND
PMID: 14748173 (View on PubMed)

Enright PL, McBurnie MA, Bittner V, Tracy RP, McNamara R, Arnold A, Newman AB; Cardiovascular Health Study. The 6-min walk test: a quick measure of functional status in elderly adults. Chest. 2003 Feb;123(2):387-98. doi: 10.1378/chest.123.2.387.

Reference Type BACKGROUND
PMID: 12576356 (View on PubMed)

Faggiano P, D'Aloia A, Gualeni A, Brentana L, Dei Cas L. The 6 minute walking test in chronic heart failure: indications, interpretation and limitations from a review of the literature. Eur J Heart Fail. 2004 Oct;6(6):687-91. doi: 10.1016/j.ejheart.2003.11.024. No abstract available.

Reference Type BACKGROUND
PMID: 15542403 (View on PubMed)

[I National Consensus of Cardiovascular Rehabilitation]. Arq Bras Cardiol. 1997 Oct;69(4):267-91. No abstract available. Portuguese.

Reference Type BACKGROUND
PMID: 9595722 (View on PubMed)

Guazzi M, Dickstein K, Vicenzi M, Arena R. Six-minute walk test and cardiopulmonary exercise testing in patients with chronic heart failure: a comparative analysis on clinical and prognostic insights. Circ Heart Fail. 2009 Nov;2(6):549-55. doi: 10.1161/CIRCHEARTFAILURE.109.881326. Epub 2009 Sep 28.

Reference Type BACKGROUND
PMID: 19919979 (View on PubMed)

Guyatt GH, Sullivan MJ, Thompson PJ, Fallen EL, Pugsley SO, Taylor DW, Berman LB. The 6-minute walk: a new measure of exercise capacity in patients with chronic heart failure. Can Med Assoc J. 1985 Apr 15;132(8):919-23.

Reference Type BACKGROUND
PMID: 3978515 (View on PubMed)

Moura LZ, Guimaraes GV, Pires PV, Cruz F, Stopa G, Bocchi EA. Exercise chemosensitivity in heart failure: ventilatory, chronotropic and neurohormonal responses. Arq Bras Cardiol. 2010 Sep;95(3):381-91. doi: 10.1590/s0066-782x2010005000110. Epub 2010 Aug 13.

Reference Type BACKGROUND
PMID: 20721516 (View on PubMed)

Opasich C, Pinna GD, Mazza A, Febo O, Riccardi R, Riccardi PG, Capomolla S, Forni G, Cobelli F, Tavazzi L. Six-minute walking performance in patients with moderate-to-severe heart failure; is it a useful indicator in clinical practice? Eur Heart J. 2001 Mar;22(6):488-96. doi: 10.1053/euhj.2000.2310.

Reference Type BACKGROUND
PMID: 11237544 (View on PubMed)

Pinsky MR. Cardiovascular issues in respiratory care. Chest. 2005 Nov;128(5 Suppl 2):592S-597S. doi: 10.1378/chest.128.5_suppl_2.592S.

Reference Type BACKGROUND
PMID: 16306058 (View on PubMed)

Rajendra Acharya U, Paul Joseph K, Kannathal N, Lim CM, Suri JS. Heart rate variability: a review. Med Biol Eng Comput. 2006 Dec;44(12):1031-51. doi: 10.1007/s11517-006-0119-0. Epub 2006 Nov 17.

Reference Type BACKGROUND
PMID: 17111118 (View on PubMed)

Santos RD; Sociedade Brasileira de Cardiologia. [III Brazilian Guidelines on Dyslipidemias and Guideline of Atherosclerosis Prevention from Atherosclerosis Department of Sociedade Brasileira de Cardiologia]. Arq Bras Cardiol. 2001 Nov;77 Suppl 3:1-48. No abstract available. Portuguese.

Reference Type BACKGROUND
PMID: 11781591 (View on PubMed)

Sparrow J, Parameshwar J, Poole-Wilson PA. Assessment of functional capacity in chronic heart failure: time-limited exercise on a self-powered treadmill. Br Heart J. 1994 Apr;71(4):391-4. doi: 10.1136/hrt.71.4.391.

Reference Type BACKGROUND
PMID: 8198895 (View on PubMed)

Bittner V, Weiner DH, Yusuf S, Rogers WJ, McIntyre KM, Bangdiwala SI, Kronenberg MW, Kostis JB, Kohn RM, Guillotte M, et al. Prediction of mortality and morbidity with a 6-minute walk test in patients with left ventricular dysfunction. SOLVD Investigators. JAMA. 1993 Oct 13;270(14):1702-7.

Reference Type RESULT
PMID: 8411500 (View on PubMed)

Carvalho EE, Costa DC, Crescencio JC, Santi GL, Papa V, Marques F, Schmidt A, Marin-Neto JA, Simoes MV, Gallo Junior L. Heart failure: comparison between six-minute walk test and cardiopulmonary test. Arq Bras Cardiol. 2011 Jul;97(1):59-64. doi: 10.1590/s0066-782x2011005000056. Epub 2011 May 6. English, Portuguese, Spanish.

Reference Type RESULT
PMID: 21552646 (View on PubMed)

Correa FR, da Silva Alves MA, Bianchim MS, Crispim de Aquino A, Guerra RL, Dourado VZ. Heart rate variability during 6-min walk test in adults aged 40 years and older. Int J Sports Med. 2013 Feb;34(2):111-5. doi: 10.1055/s-0032-1321888. Epub 2012 Sep 12.

Reference Type RESULT
PMID: 22972244 (View on PubMed)

Enright PL, Sherrill DL. Reference equations for the six-minute walk in healthy adults. Am J Respir Crit Care Med. 1998 Nov;158(5 Pt 1):1384-7. doi: 10.1164/ajrccm.158.5.9710086.

Reference Type RESULT
PMID: 9817683 (View on PubMed)

Rector TS, Cohn JN. Assessment of patient outcome with the Minnesota Living with Heart Failure questionnaire: reliability and validity during a randomized, double-blind, placebo-controlled trial of pimobendan. Pimobendan Multicenter Research Group. Am Heart J. 1992 Oct;124(4):1017-25. doi: 10.1016/0002-8703(92)90986-6.

Reference Type RESULT
PMID: 1529875 (View on PubMed)

da Silva MA, Sousa AG, Schargodsky H. [Risk factors for acute myocardial infarction in Brazil. FRICAS Study]. Arq Bras Cardiol. 1998 Nov;71(5):667-75. Portuguese.

Reference Type RESULT
PMID: 10347949 (View on PubMed)

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

dont have

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.